Peptides 101

What a peptide actually is

Between a small molecule and a biologic sits a class of medicine with the specificity of one and the manufacturability of the other.

A definition, precisely

A peptide is a short chain of amino acids — conventionally between 2 and 50 residues, with a molecular weight between roughly 500 and 5,000 daltons. Below that range you are generally talking about small molecules; above it, about proteins and biologics.

That size is not a trivia fact. It is the reason the whole category exists. A peptide is small enough to be manufactured by chemical synthesis, and large enough to fold into a shape that binds one receptor rather than many.

Why the middle is interesting

Small molecules — aspirin, statins, SSRIs — are cheap to make and easy to swallow, but they are promiscuous. Low specificity means off-target effects and broad toxicity profiles.

Biologics — monoclonal antibodies, insulin — are extraordinarily specific, but they are grown in cell culture rather than synthesized, they need a cold chain, and in most indications they are administered by infusion.

Peptides sit between the two. They bind their targets with something close to biologic precision, and they can be built on a synthesis line. That combination is why a class of medicine that once lived in hospitals now lives in a refrigerator at home.

What happens after the injection

Peptides are metabolized to amino acids — the body’s native building blocks. They are typically self-administered subcutaneously, which is the same route that roughly one in eight U.S. adults has already used with a GLP-1.

That familiarity matters more than it sounds. The behavioral and regulatory scaffolding for at-home subcutaneous injection was built by the GLP-1 wave. Every peptide that follows inherits it.

What this article does not tell you

It does not tell you whether any specific peptide is appropriate for you. That is a question for a licensed provider who knows your history, your medications and your goals.

It also does not make any claim about what a particular molecule does in the body. Where the evidence is thin, we would rather say so than fill the space.

Sources

  • FDA Orange Book
  • USP monograph database
  • KFF Health Tracking Poll, 2024 — GLP-1 use among U.S. adults
  • [TBD-CITATION] Peptide therapeutics review — pending selection by the scientific team

We do not publish a citation we have not read. A marker reading [TBD-CITATION] means the reference is still being selected.